![Liisa Irmeli Laitinen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Liisa Irmeli Laitinen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Extinct | Biotechnology | 14 | |
Icosagen AS
![]() Icosagen AS Pharmaceuticals: MajorHealth Technology Icosagen AS is a biotechnology company based in Tartu, Estonia. Established in 1999, the Estonian company offers contract research, development, and manufacturing services to biotechnology and pharmaceutical companies. With a team of over 190 experts, Icosagen specializes in discovering and producing recombinant proteins and antibodies. The private company comprises four entities, including Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and Icopark OÜ. Icosagen provides antibody discovery and development services, food microbiology testing, and GMP-compliant high productivity CHO-based stable cell line development. The company collaborates with Future Style to offer its antigens and antibodies. Icosagen also supports functional activity testing of products in suitable cell-based activity assays.
1
| Private Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Liisa Irmeli Laitinen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Helsinki | College/University | Chief Tech/Sci/R&D Officer Doctorate Degree Graduate Degree | |
SOLIGENIX, INC. | Pharmaceuticals: Major | Chairman | |
Vivoxid Oy
![]() Vivoxid Oy BiotechnologyHealth Technology Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland. | Biotechnology | Chairman | |
Teitur Trophics ApS
![]() Teitur Trophics ApS BiotechnologyHealth Technology Teitur Trophics ApS develops novel treatments. The company is based in Aarhus, Denmark. The Danish company was founded by Simon Mølgaard, Mathias Kaas Ollendorff, Anders Dalby, Simon Glerup. Simon Mølgaard has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Suomen Bioteollisuus ry | Director/Board Member | ||
Helsinki Innovation Services Ltd.
![]() Helsinki Innovation Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of University of Helsinki, Helsinki Innovation Services Ltd. is a company that provides business and innovation-related consulting services. The company is based in Helsinki, Finland. | Miscellaneous Commercial Services | Chief Operating Officer | |
Innovestor Ventures Oy
![]() Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor | |
Neumirna Therapeutics ApS | Biotechnology | Director/Board Member | |
Tribune Therapeutics AB
![]() Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
University of Eastern Finland | College/University | Undergraduate Degree | |
Innovestor Oy
![]() Innovestor Oy Investment ManagersFinance Innovestor Oy is a venture and growth equity firm headquartered in Helsinki, Finland. The firm was founded by Tommi Äijälä and Antti Parviainen in 2014. | Investment Managers | Private Equity Investor | |
Valo Therapeutics Oy
![]() Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
Aranda Pharma Oy
![]() Aranda Pharma Oy BiotechnologyHealth Technology Aranda Pharma Ltd. engages in the research and development of novel small molecules to combat prostate cancer and neurodegenerative diseases. The company was founded by Anu Muona, Milla Koistinaho, Jari Koistinaho, and Gundars Goldsteins in September 2015 and is headquartered in Kuopio, Finland. | Biotechnology | Founder | |
University of Kuopio | College/University | Doctorate Degree | |
NEXSTIM PLC | Medical Specialties | Director/Board Member | |
Orion Group Ltd.
![]() Orion Group Ltd. Electronics/Appliance StoresRetail Trade Orion Group Ltd. distributes and supplies computer accessories. Its products include storage media and printers. The company is headquartered in Brentford, UK. | Electronics/Appliance Stores | Corporate Officer/Principal | |
Karyon-CTT Oy
![]() Karyon-CTT Oy Miscellaneous Commercial ServicesCommercial Services Karyon-CTT Oy discovers and develops novel and innovative peptide-based tumor targeting systems. Its Targeting Units (TU) are intended for delivery of diagnostic imaging agents or therapeutic compounds to cancer tissue. The company was founded in 2006 and is headquartered in Helsinki, Finland. | Miscellaneous Commercial Services | Chief Executive Officer | |
ÅLANDSBANKEN ABP | Major Banks | Corporate Officer/Principal | |
Independent Television Commission | Corporate Officer/Principal | ||
BBC Trust
![]() BBC Trust Miscellaneous Commercial ServicesCommercial Services BBC Trust operates as a governing body of British Broadcasting Corp. It provides services through television, radio, online and red button. The company was founded in January 2007 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Northern Ireland Blood Transfusion Ser | Corporate Officer/Principal | ||
Icosagen Cell Factory Ltd. | Chief Executive Officer | ||
University of Tartu | College/University | Corporate Officer/Principal | |
NORA BANK | Major Banks | Director/Board Member | |
Locnet Oy | Chief Executive Officer | ||
KC-Holding 3 Oy
![]() KC-Holding 3 Oy MiscellaneousMiscellaneous KC-Holding 3 Oy provides financial management services. The company was founded on March 26, 2007 and is headquartered in Helsinki, Finland. | Miscellaneous | Chairman | |
Telia Finland Oyj
![]() Telia Finland Oyj Major TelecommunicationsCommunications Telia Finland Oyj provides mobile telecommunication services. It offers mobile telecommunications services to residential subscribers through independent distributors and to corporate subscribers through direct sales force. The company is headquartered in Helsinki, Finland. | Major Telecommunications | Comptroller/Controller/Auditor | |
International Institute for Management Development | College/University | Masters Business Admin | |
Aalto University | College/University | Graduate Degree | |
Sitra Management Oy
![]() Sitra Management Oy Investment ManagersFinance Sitra Management Oy (Sitra) is a venture capital subsidiary of the Government of Finland founded in 1967. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor | |
Pharmatory Oy
![]() Pharmatory Oy Medical DistributorsDistribution Services Pharmatory Oy provides pharmaceutical ingredients and related services. It specializes in route scouting, process research and development, scale-up and cGMP manufacturing of key intermediates and active pharmaceutical ingredients (APIs) with focus on quality operation and timely delivery. The company was founded in 2001 and is headquartered in Oulu, Finland. | Medical Distributors | Director/Board Member | |
National Technology Agency | Chief Tech/Sci/R&D Officer | ||
Charles River Discovery Research Services Finland Oy
![]() Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Tenboron Oy
![]() Tenboron Oy Medical SpecialtiesHealth Technology Tenboron Oy engages in the development of new boron carriers and imaging agents for use in boron neutron capture therapy. The company was founded by Erkki Tenhunen and Rabbe Erik Kasten Lähde Slätis on December 21, 2010 and is headquartered in Helsinki, Finland. | Medical Specialties | Founder | |
Cysteine Pharma, Inc. | Chairman | ||
THERIVA BIOLOGICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
OncoTracker, Inc.
![]() OncoTracker, Inc. Pharmaceuticals: MajorHealth Technology OncoTracker, Inc. is a medical diagnostics company focusing on immuno-oncology. The firm involves research and drug discovery in hematological cancers. It provides therapies, sBCMA testing, and testing and services. The company was founded by James R Berenson in 2014 and is headquartered in West Hollywood, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
IMMUNOPRECISE ANTIBODIES LTD. | Biotechnology | Chairman | |
Athena Bioventures, Inc
![]() Athena Bioventures, Inc Financial ConglomeratesFinance Athena Bioventures, Inc provides investment services. The private company is based in La Jolla, CA. The CEO of the company is Geraldine Kuo. | Financial Conglomerates | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
ApoLife, Inc.
![]() ApoLife, Inc. Miscellaneous Commercial ServicesCommercial Services ApoLife, Inc. provides screening and lab services. James S. Kuo has been the CEO of the American company since 2012. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistics
International
Finland | 29 |
United States | 10 |
United Kingdom | 4 |
Denmark | 3 |
Sweden | 3 |
Sectoral
Health Technology | 15 |
Finance | 10 |
Commercial Services | 9 |
Consumer Services | 8 |
Retail Trade | 2 |
Operational
Director/Board Member | 30 |
Chief Executive Officer | 20 |
Chairman | 18 |
Corporate Officer/Principal | 13 |
Founder | 8 |
Most connected contacts
- Stock Market
- Insiders
- Liisa Irmeli Laitinen
- Company connections